The George Institute for Global Health and Monash University is inviting GP practices to participate in the START trial, a National Health and Medical Research Council (NHMRC)-funded study.
The START trial aims to evaluate the comparative effects of metformin versus the SGLT2 inhibitor dapagliflozin, on annual decline in eGFR, when used as first-line therapy in people with newly diagnosed type 2 diabetes.
Participating general practices will assist the trial team to identify potential participants.
All GP practices involved will benefit from remuneration ($150) per randomised participant to support any administrative costs which may arise. Participation can be self-recorded as a CPD activity and 2 CPD points per hour can be claimed for participating in research.
If your practice would like to participate email START-trial@georgeinstitute.org.au or phone 8052 4343.
Download the flyer
This article appeared in Practice Pulse on Wednesday, 7 December 2022. If you are a GP, practice nurse or practice manager in South Western Sydney and do not get the weekly Practice Pulse email, speak to your Practice Support Officer.